华纳药厂 (688799)

Hunan Warrant Pharmaceutical Co., Ltd.

KSH

Tags

Specialized-Sophisticated-Distinctive-Innovative EnterprisesInnovative DrugsBroker Heavy PositionsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareSynthetic BiologyHelicobacter PyloriSTAR Market 200 IndexHigh-Performing StocksHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 13132.00
  • Circulating A-Shares(W): 13132.00
  • Earnings Per Share(RMB): 1.5800
  • Net Assets Per Share(RMB): 15.1700
  • Operating Revenue(W RMB): 108582.45
  • Total Profit(W RMB): 21583.01
  • **Net Profit Attributable to Parent(W RMB) **: 20712.36
  • Net Profit Growth Rate(%): 30.75
  • Weighted Return on Equity(%): 11.0100
  • Operating Cash Flow Per Share(RMB): 1.5710
  • Undistributed Profit Per Share(RMB): 7.3348
  • Capital Reserve Per Share(RMB): 6.4780

2. Main Business

The main business covers:

  • Research, production, and sales of chemical drug preparations
  • Research, production, and sales of chemical pharmaceutical raw materials
  • Research, production, and sales of traditional Chinese medicine preparations

3. Company Basic Information

  • Company Name: Hunan Warrant Pharmaceutical Co., Ltd.
  • Listing Date: 2021-07-13
  • Industry: Pharmaceutical Manufacturing
  • Address: Building C6-C7, Jinrui Lugu Technology Park, No. 28 Lutian Road, Yuelu District, Changsha City, Hunan Province
  • Website: https://www.warrant.com.cn
  • Company Profile: On September 30, 2015, Warrant Co., Ltd. obtained the "Enterprise Name Change Approval Notice" ((Xiang) Registration Internal Name Pre-approval No. [2015]15046) issued by the Hunan Provincial Administration for Industry and Commerce, pre-approving the proposed joint stock limited company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hunan Warrant Pharmaceutical Investment Partnership (Limited Partnership) General Legal Person 5223.68 39.78
2 Everbright Pharmaceutical Health Theme Equity Initiated Securities Investment Fund Class A Fund 122.94 0.94
3 China Europe Enjoy Life Hybrid Securities Investment Fund Class A Fund 108.91 0.83
4 Huatai Securities Co., Ltd. Securities Firm 105.35 0.80
5 Caitong Advantage Industry Rotation Hybrid Securities Investment Fund Class A Fund 46.38 0.35
6 Caitong Science and Technology Innovation Theme Flexible Allocation Hybrid Securities Investment Fund (LOF) Fund 34.89 0.27
7 Caitong Science and Technology Innovation Hybrid Securities Investment Fund Class A Fund 25.79 0.20
8 China Merchants Yutai Hybrid Securities Investment Fund Fund 7.79 0.06
9 Caitong Fusheng Multi-Strategy Hybrid Initiated Securities Investment Fund (LOF) Class A Fund 6.39 0.05

5. Concept Sectors

  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Securities Firms Heavy Positions
  • Specialized, Refined, Special and New (SRSN) Enterprises
  • Star Market 200

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information